Basilea Pharmaceutica (Switzerland) Price on December 3, 2024

BSLN Stock  CHF 40.65  0.45  1.09%   
If you're considering investing in Basilea Stock, it is important to understand the factors that can impact its price. As of today, the current price of Basilea Pharmaceutica stands at 40.65, as last reported on the 13th of December 2024, with the highest price reaching 41.40 and the lowest price hitting 40.60 during the day. Basilea Pharmaceutica secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the company had a -0.11% return per unit of risk over the last 3 months. Basilea Pharmaceutica AG exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Basilea Pharmaceutica's Mean Deviation of 1.02, risk adjusted performance of (0.08), and Standard Deviation of 1.29 to double-check the risk estimate we provide.
  
Basilea Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1121

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBSLN

Estimated Market Risk

 1.3
  actual daily
11
89% of assets are more volatile

Expected Return

 -0.15
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.11
  actual daily
0
Most of other assets perform better
Based on monthly moving average Basilea Pharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Basilea Pharmaceutica by adding Basilea Pharmaceutica to a well-diversified portfolio.

Basilea Pharmaceutica Valuation on December 3, 2024

It is possible to determine the worth of Basilea Pharmaceutica on a given historical date. On December 3, 2024 Basilea was worth 40.95 at the beginning of the trading date compared to the closed value of 40.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Basilea Pharmaceutica stock. Still, in general, we apply an absolute valuation method to find Basilea Pharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Basilea Pharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Basilea Pharmaceutica's related companies.
 Open High Low Close Volume
  41.80    41.90    40.70    40.95    21,108  
12/03/2024
  40.95    41.35    40.40    40.90    18,052  
  40.75    41.00    39.60    40.10    41,664  
Backtest Basilea Pharmaceutica  |  Basilea Pharmaceutica History  |  Basilea Pharmaceutica Valuation   PreviousNext  
Open Value
40.95
40.9
Closing Value
44.84
Upside

Basilea Pharmaceutica Trading Date Momentum on December 3, 2024

On December 04 2024 Basilea Pharmaceutica AG was traded for  40.10  at the closing time. The highest price during the trading period was 41.00  and the lowest recorded bid was listed for  39.60 . The volume for the day was 41.7 K. This history from December 4, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 1.96% . The overall trading delta to the current price is 0.24% .

Basilea Pharmaceutica Fundamentals Correlations and Trends

By evaluating Basilea Pharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Basilea Pharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Basilea financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Basilea Pharmaceutica Stock history

Basilea Pharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Basilea is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Basilea Pharmaceutica will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Basilea Pharmaceutica stock prices may prove useful in developing a viable investing in Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company was founded in 2000 and is headquartered in Basel, Switzerland. BASILEA N operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange. It employs 160 people.

Basilea Pharmaceutica Stock Technical Analysis

Basilea Pharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Basilea Pharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Basilea Pharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Basilea Pharmaceutica Period Price Range

Low
December 13, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Basilea Pharmaceutica AG cannot be verified against its exchange. Please verify the symbol is currently traded on SIX Swiss Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Basilea Pharmaceutica December 13, 2024 Market Strength

Market strength indicators help investors to evaluate how Basilea Pharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Basilea Pharmaceutica shares will generate the highest return on investment. By undertsting and applying Basilea Pharmaceutica stock market strength indicators, traders can identify Basilea Pharmaceutica AG entry and exit signals to maximize returns

Basilea Pharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Basilea Pharmaceutica's price direction in advance. Along with the technical and fundamental analysis of Basilea Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Basilea to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Basilea Stock Analysis

When running Basilea Pharmaceutica's price analysis, check to measure Basilea Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Basilea Pharmaceutica is operating at the current time. Most of Basilea Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Basilea Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Basilea Pharmaceutica's price. Additionally, you may evaluate how the addition of Basilea Pharmaceutica to your portfolios can decrease your overall portfolio volatility.